Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation. | Hum Mutat | 2026 | 42100492 | PubTator, text mining | PubMed |
| A systematic review on the impact of type 2 diabetes on Leydig and Sertoli cells: Molecular mechanisms and functional consequences. | Diabetes Metab Syndr | 2026 | 42097114 | PubTator, text mining | PubMed |
| Correction: CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. | Cell Death Dis | 2026 | 42031705 | PubTator, text mining | PubMed |
| Reprogramming Hepatic Resilience: BMK1 as a Cytoprotective Axis in Liver Ischemia-reperfusion Injury. | Transplantation | 2026 | 42024323 | PubTator, text mining | PubMed |
| The transcription factor Rlm1 couples the MAPK Slt2/ERK1 pathway to the IRE1-driven unfolded protein response. | Commun Biol | 2026 | 42014513 | PubTator, text mining | PubMed |
| Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma. | Signal Transduct Target Ther | 2026 | 41946693 | PubTator, text mining | PubMed |
| AXL is a novel ERK5/KLF4 target in MEK inhibitor-treated melanoma. | Neoplasia | 2026 | 41916083 | PubTator, text mining | PubMed |
| A different MAPK, ERK5 plays a critical role in cell specification and differentiation. | Biochem Biophys Rep | 2026 | 41909153 | PubTator, text mining | PubMed |
| ERKed by too much signaling: from oncogenic driver to therapeutic vulnerability. | Cell Mol Life Sci | 2026 | 41865130 | PubTator, text mining | PubMed |
| Mechanoreceptor-mediated adaptations to physical exercise: from acute responses to long-term training effects. | Cell Mol Life Sci | 2026 | 41854727 | PubTator, text mining | PubMed |
| Dose-Dependent Inhibition of Protein Glycosylation Reveals Crosstalk between Glycosylation and Phosphorylation in EGF Signaling Pathways. | Anal Chem | 2026 | 41843583 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
| VCAN Is Essential for ERK5-Driven Tumorigenesis in Soft Tissue Sarcoma. | Int J Biol Sci | 2026 | 41800245 | PubTator, text mining | PubMed |
| MAPK ERK5 is a novel regulator of MHC-I in cancer cells. | Cell Commun Signal | 2026 | 41796389 | PubTator, text mining | PubMed |
| Ultrasound-integrated biofabrication of aligned piscine muscle tissue. | Food Res Int | 2026 | 41794464 | PubTator, text mining | PubMed |
Integrating AI-Based Clustering, Molecular Dynamics, and Binding Energy Analysis to Elucidate Conformational Dynamics and Binding Selectivity in Extracellular Signal-Regulated Kinases 1 and 2 Complexes. | Bioinform Biol Insights | 2026 | 41789351 | PubTator, text mining | PubMed |
| XMD8-92 and JWG-045 exhibit anti-ferroptotic activities, independently of inhibiting ERK5. | Sci Rep | 2026 | 41764307 | PubTator, text mining | PubMed |
| Editorial: Challenges and opportunities in tumor metabolomics. | Front Mol Biosci | 2026 | 41756027 | PubTator, text mining | PubMed |
| Integration of Fibroblast-Populated Collagen Lattices and Perfusable Micro-Physiological Systems: A Mechanobiologically Unified Framework for Living Devices. | Micromachines (Basel) | 2026 | 41753826 | PubTator, text mining | PubMed |
| Targeting the JNK Gatekeepers: Structural Evolution and Medicinal Chemistry of MKK4 and MKK7 Inhibitors. | Molecules | 2026 | 41752451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=2